Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Cardiff Oncology Inc CRDF

Healthcare Biotechnology
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated ongoing or planned trials in... see more

Current News (NDAQ:CRDF)

Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025

GlobeNewswire December 8, 2025

Cardiff Oncology to Present at Sidoti's Year-End Virtual Investor Conference

GlobeNewswire December 8, 2025

Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire November 24, 2025

Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update

GlobeNewswire November 6, 2025

Cardiff Oncology to Participate in Two Upcoming Investor Conferences

GlobeNewswire November 4, 2025

Cardiff Oncology to Participate in Two Upcoming Investor Conferences

GlobeNewswire October 2, 2025

Cardiff Oncology to Participate in Three Upcoming Investor Conferences

GlobeNewswire August 28, 2025

Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)

GlobeNewswire July 29, 2025

Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update

GlobeNewswire July 29, 2025
View More News ››

Opinion & Analysis (NDAQ:CRDF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CRDF)

Enjoying your "capital gains"?

So you people enjoying your "capital gains" from a couple of days ago? Lol, "capital gains."
Pumpsydumpsy - June 28, 2024

Looking to add a position

Stock looks like a buy at these prices
biggdeal - May 7, 2021

RE:Small add here.....

News release this a.m........added to position.  Cheers !
Iseneschal - January 26, 2021

Small add here.....

will add on weakness if continuation occurs. Cheers!
Iseneschal - January 19, 2021

RE:What a great day today

What a nice run so far.   Taking some profits along the way though.
mevani - August 3, 2020

What a great day today

Took some profit  though today.  
mevani - May 15, 2020
View more Bullboard ››

Lithium Ionic Corp

Lithium Ionic Corp

Lithium Ionic Corp., together with its subsidiaries, engages in the acquisition, exploration, and development of lithium ...
View More »

Podcasts